Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Malika Aid is active.

Publication


Featured researches published by Malika Aid.


Nucleic Acids Research | 2007

Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells

Véronique Bourdeau; Julie Deschênes; David Laperrière; Malika Aid; John H. White; Sylvie Mader

Estrogen receptors (ERs), which mediate the proliferative action of estrogens in breast cancer cells, are ligand-dependent transcription factors that regulate expression of their primary target genes through several mechanisms. In addition to direct binding to cognate DNA sequences, ERs can be recruited to DNA through other transcription factors (tethering), or affect gene transcription through modulation of signaling cascades by non-genomic mechanisms of action. To better characterize the mechanisms of gene regulation by estrogens, we have identified more than 700 putative primary and about 1300 putative secondary target genes of estradiol in MCF-7 cells through microarray analysis performed in the presence or absence of the translation inhibitor cycloheximide. Although siRNA-mediated inhibition of ERα expression antagonized the effects of estradiol on up- and down-regulated primary target genes, estrogen response elements (EREs) were enriched only in the vicinity of up-regulated genes. Binding sites for several other transcription factors, including proteins known to tether ERα, were enriched in up- and/or down-regulated primary targets. Secondary estrogen targets were particularly enriched in sites for E2F family members, several of which were transcriptionally regulated by estradiol, consistent with a major role of these factors in mediating the effects of estrogens on gene expression and cellular growth.


Antimicrobial Agents and Chemotherapy | 2011

Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans

Sabrina Schubert; Katherine S. Barker; Sadri Znaidi; Sabrina Schneider; Franziska Dierolf; Nico Dunkel; Malika Aid; Geneviève Boucher; P. David Rogers; Martine Raymond; Joachim Morschhäuser

ABSTRACT Constitutive overexpression of the Mdr1 efflux pump is an important mechanism of acquired drug resistance in the yeast Candida albicans. The zinc cluster transcription factor Mrr1 is a central regulator of MDR1 expression, but other transcription factors have also been implicated in MDR1 regulation. To better understand how MDR1-mediated drug resistance is achieved in this fungal pathogen, we studied the interdependence of Mrr1 and two other MDR1 regulators, Upc2 and Cap1, in the control of MDR1 expression. A mutated, constitutively active Mrr1 could upregulate MDR1 and confer drug resistance in the absence of Upc2 or Cap1. On the other hand, Upc2 containing a gain-of-function mutation only slightly activated the MDR1 promoter, and this activation depended on the presence of a functional MRR1 gene. In contrast, a C-terminally truncated, activated form of Cap1 could upregulate MDR1 in a partially Mrr1-independent fashion. The induction of MDR1 expression by toxic chemicals occurred independently of Upc2 but required the presence of Mrr1 and also partially depended on Cap1. Transcriptional profiling and in vivo DNA binding studies showed that a constitutively active Mrr1 binds to and upregulates most of its direct target genes in the presence or absence of Cap1. Therefore, Mrr1 and Cap1 cooperate in the environmental induction of MDR1 expression in wild-type C. albicans, but gain-of-function mutations in either of the two transcription factors can independently mediate efflux pump overexpression and drug resistance.


Nature Communications | 2011

ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters

Swneke D. Bailey; Xiaoyang Zhang; Kinjal Desai; Malika Aid; Olivia Corradin; Richard Cowper-Sal·lari; Batool Akhtar-Zaidi; Peter C. Scacheri; Benjamin Haibe-Kains; Mathieu Lupien

Chromatin interactions connect distal regulatory elements to target gene promoters guiding stimulus- and lineage-specific transcription. Few factors securing chromatin interactions have so far been identified. Here, by integrating chromatin interaction maps with the large collection of transcription factor-binding profiles provided by the ENCODE project, we demonstrate that the zinc-finger protein ZNF143 preferentially occupies anchors of chromatin interactions connecting promoters with distal regulatory elements. It binds directly to promoters and associates with lineage-specific chromatin interactions and gene expression. Silencing ZNF143 or modulating its DNA-binding affinity using single-nucleotide polymorphisms (SNPs) as a surrogate of site-directed mutagenesis reveals the sequence dependency of chromatin interactions at gene promoters. We also find that chromatin interactions alone do not regulate gene expression. Together, our results identify ZNF143 as a novel chromatin-looping factor that contributes to the architectural foundation of the genome by providing sequence specificity at promoters connected with distal regulatory elements. Chromatin interactions can connect distal regulatory elements to promoters via protein factors, but few such factors have been identified. Here, the authors show that zinc-finger protein ZNF143 is a sequence-specific chromatin-looping factor that connects promoters with distal regulatory elements.


Cell | 2017

Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys

Malika Aid; Peter Abbink; Rafael A. Larocca; Michael Boyd; Ramya Nityanandam; Ovini Nanayakkara; Amanda J. Martinot; Edward T. Moseley; Eryn Blass; Erica N. Borducchi; Abishek Chandrashekar; Amanda L. Brinkman; Katherine Molloy; David Jetton; Lawrence J. Tartaglia; Jinyan Liu; Katharine Best; Alan S. Perelson; Rafael De La Barrera; Mark G. Lewis; Dan H. Barouch

Zika virus (ZIKV) is associated with severe neuropathology in neonates as well as Guillain-Barré syndrome and other neurologic disorders in adults. Prolonged viral shedding has been reported in semen, suggesting the presence of anatomic viral reservoirs. Here we show that ZIKV can persist in cerebrospinal fluid (CSF) and lymph nodes (LN) of infected rhesus monkeys for weeks after virus has been cleared from peripheral blood, urine, and mucosal secretions. ZIKV-specific neutralizing antibodies correlated with rapid clearance of virus in peripheral blood but remained undetectable in CSF for the duration of the study. Viral persistence in both CSF and LN correlated with upregulation of mechanistic target of rapamycin (mTOR), proinflammatory, and anti-apoptotic signaling pathways, as well as downregulation of extracellular matrix signaling pathways. These data raise the possibility that persistent or occult neurologic and lymphoid disease may occur following clearance of peripheral virus in ZIKV-infected individuals.


Cell | 2017

Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells

Mauro Gaya; Patricia Barral; Marianne Burbage; Shweta Aggarwal; Beatriz Montaner; Andrew Warren Navia; Malika Aid; Carlson Tsui; Paula Maldonado; Usha Nair; Khader Ghneim; Padraic G. Fallon; Rafick-Pierre Sekaly; Dan H. Barouch; Alex K. Shalek; Andreas Bruckbauer; Jessica Strid; Facundo D. Batista

Summary B cells constitute an essential line of defense from pathogenic infections through the generation of class-switched antibody-secreting cells (ASCs) in germinal centers. Although this process is known to be regulated by follicular helper T (TfH) cells, the mechanism by which B cells initially seed germinal center reactions remains elusive. We found that NKT cells, a population of innate-like T lymphocytes, are critical for the induction of B cell immunity upon viral infection. The positioning of NKT cells at the interfollicular areas of lymph nodes facilitates both their direct priming by resident macrophages and the localized delivery of innate signals to antigen-experienced B cells. Indeed, NKT cells secrete an early wave of IL-4 and constitute up to 70% of the total IL-4-producing cells during the initial stages of infection. Importantly, the requirement of this innate immunity arm appears to be evolutionarily conserved because early NKT and IL-4 gene signatures also positively correlate with the levels of neutralizing antibodies in Zika-virus-infected macaques. In conclusion, our data support a model wherein a pre-TfH wave of IL-4 secreted by interfollicular NKT cells triggers the seeding of germinal center cells and serves as an innate link between viral infection and B cell immunity.


Journal of Immunology | 2016

Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells

Nicholas M. Provine; Rafael A. Larocca; Malika Aid; Pablo Penaloza-MacMaster; Alexander Badamchi-Zadeh; Erica N. Borducchi; Kathleen Yates; Peter Abbink; Marinela Kirilova; David Ng’ang’a; Jonathan Bramson; W. Nicholas Haining; Dan H. Barouch

CD4+ T cell help is critical for optimal CD8+ T cell memory differentiation and maintenance in many experimental systems. In addition, many reports have identified reduced primary CD8+ T cell responses in the absence of CD4+ T cell help, which often coincides with reduced Ag or pathogen clearance. In this study, we demonstrate that absence of CD4+ T cells at the time of adenovirus vector immunization of mice led to immediate impairments in early CD8+ T cell functionality and differentiation. Unhelped CD8+ T cells exhibited a reduced effector phenotype, decreased ex vivo cytotoxicity, and decreased capacity to produce cytokines. This dysfunctional state was imprinted within 3 d of immunization. Unhelped CD8+ T cells expressed elevated levels of inhibitory receptors and exhibited transcriptomic exhaustion and anergy profiles by gene set enrichment analysis. Dysfunctional, impaired effector differentiation also occurred following immunization of CD4+ T cell–deficient mice with a poxvirus vector. This study demonstrates that following priming with viral vectors, CD4+ T cell help is required to promote both the expansion and acquisition of effector functions by CD8+ T cells, which is accomplished by preventing immediate dysfunction.


Science immunology | 2016

Adenovirus serotype 5 vaccine vectors trigger IL-27–dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function

Rafael A. Larocca; Nicholas M. Provine; Malika Aid; M. Justin Iampietro; Erica N. Borducchi; Alexander Badamchi-Zadeh; Peter Abbink; David Ng’ang’a; Christine A. Bricault; Eryn Blass; Pablo Penaloza-MacMaster; Kathryn E. Stephenson; Dan H. Barouch

Negative immunologic regulatory pathways of vaccine vectors suppress antigen-specific CD8+ T cell responses. Rejuvenating viral vectors Adenovirus serotype 5 (Ad5) vaccine vectors elicit mixed responses—they induce protective CD8+ T cells, but these cells may be partially exhausted. Now, Larocca et al. demonstrate that this exhausted phenotype may result from Ad5 vector–induced antigen-specific CD4+ T cells that express interleukin-10 (IL-10) and programmed cell death 1 (PD-1) in both mice and macaques. These IL-10+CD4+ T cells suppress the vaccine-induced CD8+ T cell response, and their inhibitory function may depend in part on IL-27. These data suggest that targeting this inhibitory pathway may enhance protection of viral vector–based vaccines. Adenovirus serotype 5 (Ad5) vaccine vectors elicit robust CD8+ T cell responses, but these responses typically exhibit a partially exhausted phenotype. However, the immunologic mechanism by which Ad5 vectors induce dysfunctional CD8+ T cells has not been elucidated previously. Here, we demonstrate that, after immunization of B6 mice, Ad5 vectors elicit antigen-specific IL-10+CD4+ T cells with a distinct transcriptional profile in a dose-dependent fashion. In rhesus monkeys, we similarly observed up-regulated expression of interleukin-10 (IL-10) and programmed cell death 1 (PD-1) by CD4+ T cells after Ad5 vaccination. These cells markedly suppressed vaccine-elicited CD8+ T cell responses in mice, and IL-10 blockade increased the frequency and functionality of antigen-specific CD8+ T cells, as well as improved protective efficacy against challenge with recombinant Listeria monocytogenes. Moreover, induction of these inhibitory IL-10+CD4+ T cells correlated with IL-27 expression, and IL-27 blockade substantially improved CD4+ T cell functionality. These data highlight a role for IL-27 in the induction of inhibitory IL-10+CD4+ T cells, which suppress CD8+ T cell magnitude and function following Ad5 vector immunization. A deeper understanding of the cytokine networks and transcriptional profiles induced by vaccine vectors should lead to strategies to improve the immunogenicity and protective efficacy of viral vector–based vaccines.


Current Opinion in Virology | 2016

The sooner the better: innate immunity as a path toward the HIV cure.

Jeffrey Tomalka; Khader Ghneim; Sanghamitra Bhattacharyya; Malika Aid; Dan H. Barouch; Rafick Pierre Sekaly; Susan Pereira Ribeiro

To combat the diverse pathogens that infect humans, the immune system has evolved complex and diverse transcriptional signatures, which drive differential cellular and humoral responses. These signatures are induced by immune receptor sensing of pathogens and by cytokines produced at the earliest onset of infection. The specific nature of immune activation is as critical to pathogen clearance as the induction of an adaptive immune response. This is particularly true for HIV, which has developed numerous immune evasion mechanisms. In this review, we will highlight recent findings that show the differential role for early innate immune responses in promoting infection versus clearance and demonstrate the need for continued research on these pathways for development of effective HIV treatments.


Journal of Virology | 2018

Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors

Peter Abbink; Marinela Kirilova; Michael Boyd; Noe B. Mercado; Zhenfeng Li; Ramya Nityanandam; Ovini Nanayakkara; Rebecca Peterson; Rafael A. Larocca; Malika Aid; Lawrence J. Tartaglia; Tinaye Mutetwa; Eryn Blass; David Jetton; Lori F. Maxfield; Erica N. Borducchi; Alexander Badamchi-Zadeh; Scott A. Handley; Guoyan Zhao; Herbert W. Virgin; Menzo Jans Emco Havenga; Dan H. Barouch

ABSTRACT Human and chimpanzee adenovirus vectors are being developed to circumvent preexisting antibodies against common adenovirus vectors such as Ad5. However, baseline immunity to these vectors still exists in human populations. Traditional cloning of new adenovirus vaccine vectors is a long and cumbersome process that takes 2 months or more and that requires rare unique restriction enzyme sites. Here we describe a novel, restriction enzyme-independent method for rapid cloning of new adenovirus vaccine vectors that reduces the total cloning procedure to 1 week. We developed 14 novel adenovirus vectors from rhesus monkeys that can be grown to high titers and that are immunogenic in mice. All vectors grouped with the unusual adenovirus species G and show extremely low seroprevalence in humans. Rapid cloning of novel adenovirus vectors is a promising approach for the development of new vector platforms. Rhesus adenovirus vectors may prove useful for clinical development. IMPORTANCE To overcome baseline immunity to human and chimpanzee adenovirus vectors, we developed 14 novel adenovirus vectors from rhesus monkeys. These vectors are immunogenic in mice and show extremely low seroprevalence in humans. Rhesus adenovirus vectors may prove useful for clinical development.


Frontiers in Immunology | 2018

Follicular CD4 T Helper Cells As a Major HIV Reservoir Compartment: A Molecular Perspective

Malika Aid; Frank P. Dupuy; Eirini Moysi; Susan Moir; Elias K. Haddad; Jacob D. Estes; Rafick Pierre Sekaly; Constantinos Petrovas; Susan Pereira Ribeiro

Effective antiretroviral therapy (ART) has prevented the progression to AIDS and reduced HIV-related morbidities and mortality for the majority of infected individuals. However, a lifelong administration of ART is necessary, placing an inordinate burden on individuals and public health systems. Therefore, discovering therapeutic regimens able to eradicate or functionally cure HIV infection is of great importance. ART interruption leads to viral rebound highlighting the establishment and maintenance of a latent viral reservoir compartment even under long-term treatment. Follicular helper CD4 T cells (TFH) have been reported as a major cell compartment contributing to viral persistence, consequent to their susceptibility to infection and ability to release replication-competent new virions. Here, we discuss the molecular profiles and potential mechanisms that support the role of TFH cells as one of the major HIV reservoirs.

Collaboration


Dive into the Malika Aid's collaboration.

Top Co-Authors

Avatar

Dan H. Barouch

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Rafael A. Larocca

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Alexander Badamchi-Zadeh

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Eryn Blass

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Pablo Penaloza-MacMaster

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Peter Abbink

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Erica N. Borducchi

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Amanda J. Martinot

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Nicholas M. Provine

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Batool Akhtar-Zaidi

Case Western Reserve University

View shared research outputs
Researchain Logo
Decentralizing Knowledge